Barings Corporate Investors Stock Forecast, Price & News

Barings Corporate Investors (NYSE:MCI) Frequently Asked Questions

How has Barings Corporate Investors' stock been impacted by COVID-19?

Barings Corporate Investors' stock was trading at $15.84 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MCI shares have increased by 2.3% and is now trading at $16.20.
View which stocks have been most impacted by COVID-19.

Are investors shorting Barings Corporate Investors?

Barings Corporate Investors saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 1,600 shares, a decrease of 91.2% from the October 31st total of 18,200 shares. Based on an average daily volume of 21,600 shares, the short-interest ratio is currently 0.1 days.
View Barings Corporate Investors' Short Interest.

How often does Barings Corporate Investors pay dividends? What is the dividend yield for Barings Corporate Investors?

Barings Corporate Investors declared a quarterly dividend on Wednesday, October 13th. Stockholders of record on Monday, November 8th will be given a dividend of $0.24 per share on Friday, November 19th. This represents a $0.96 annualized dividend and a yield of 5.93%. The ex-dividend date is Friday, November 5th.
View Barings Corporate Investors' dividend history.

Is Barings Corporate Investors a good dividend stock?

Barings Corporate Investors pays an annual dividend of $0.96 per share and currently has a dividend yield of 5.93%. MCI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View Barings Corporate Investors' dividend history.

Who are Barings Corporate Investors' key executives?

Barings Corporate Investors' management team includes the following people:

• Mr. Clifford Michael Noreen, Chairman, Exec. Officer, Chairman of Mngrs & Pres of Babson Capital (Age 63)
• Mr. Michael L. Klofas CFA, CPA, Pres (Age 60)
• Mr. Robert Mark Shettle, Officer

Who are some of Barings Corporate Investors' key competitors?

Some companies that are related to Barings Corporate Investors include Boulder Growth & Income Fund (BIF), Nuveen Nasdaq 100 Dynamic Overwrite Fund (QQQX), Tekla Healthcare Investors (HQH), Cornerstone Strategic Value Fund (CLM), AllianceBernstein Global High Income Fund (AWF), Central Securities (CET), General American Investors (GAM), Aberdeen Asia-Pacific Income Fund (FAX), BlackRock MuniYield Quality Fund III (MYI), iShares MSCI Hong Kong ETF (EWH), SPDR Bloomberg Barclays International Treasury Bond ETF (BWX), Invesco Municipal Opportunity Trust (VMO), Apollo Investment (AINV), SLR Investment (SLRC) and PIMCO High Income Fund (PHK).
View all of MCI's competitors.

What other stocks do shareholders of Barings Corporate Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Barings Corporate Investors investors own include Barings Global Short Duration High Yield Fund (BGH), Enterprise Products Partners (EPD), Energy Transfer (ET), Eaton Vance Tax-Managed Global Diversified Equity Income Fund (EXG), International Paper (IP), Pembina Pipeline (PBA), Smith & Wesson Brands (SWBI), AT&T (T), AbbVie (ABBV) and Carnival Co. & (CCL).

What is Barings Corporate Investors' stock symbol?

Barings Corporate Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCI."

Who are Barings Corporate Investors' major shareholders?

Barings Corporate Investors' stock is owned by a variety of institutional and retail investors. Top institutional investors include Rivernorth Capital Management LLC (3.26%), Curbstone Financial Management Corp (2.06%), BHK Investment Advisors LLC (1.77%), Barings LLC (1.08%), UBS Group AG (0.86%) and Sky Investment Group LLC (0.82%). Company insiders that own Barings Corporate Investors stock include Edward P Grace III and Michael Harlan Brown.
View institutional ownership trends for Barings Corporate Investors.

Which major investors are selling Barings Corporate Investors stock?

MCI stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Benjamin F. Edwards & Company Inc., Curbstone Financial Management Corp, LPL Financial LLC, Sky Investment Group LLC, and Dumont & Blake Investment Advisors LLC.
View insider buying and selling activity for Barings Corporate Investors or view top insider-selling stocks.

Which major investors are buying Barings Corporate Investors stock?

MCI stock was purchased by a variety of institutional investors in the last quarter, including Barings LLC, Rivernorth Capital Management LLC, Advisor Group Holdings Inc., Altus Wealth Group LLC, Emfo LLC, BHK Investment Advisors LLC, Morgan Stanley, and Raymond James Financial Services Advisors Inc.. Company insiders that have bought Barings Corporate Investors stock in the last two years include Edward P Grace III, and Michael Harlan Brown.
View insider buying and selling activity for Barings Corporate Investors or or view top insider-buying stocks.

How do I buy shares of Barings Corporate Investors?

Shares of MCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Barings Corporate Investors' stock price today?

One share of MCI stock can currently be purchased for approximately $16.20.

How much money does Barings Corporate Investors make?

Barings Corporate Investors has a market capitalization of $328.24 million.

What is Barings Corporate Investors' official website?

The official website for Barings Corporate Investors is www.babsoncapital.com.